Dear Dr. Renukaprasad A R, Almost 40% of individuals with hypertension develop left ventricular hypertrophy. Hypertension-related organ damage (HMOD) significantly contributes to the development of Heart Failure (HF), particularly that with preserved ejection fraction (HFpEF). Timely identification of HMOD through echocardiography is pivotal for HFpEF management, with the European Society of Hypertension offering a standardized strategy. Notably, the EMPEROR-Preserved study highlights clinical advantages of empagliflozin in hypertensive, ischemic, or other etiologies-induced HFpEF patients. Know more on the prerequisites to address hypertension and HFpEF! Highlights:- Hypertension-related organ damage leading to consequential HF
- ESH's standardized hypertension and HFpEF approach
- EMPEROR-Preserved study implications
|
No comments:
Post a Comment